slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 226,681-226,710
Pages 10,126
Rows per page 30
Component
226,681-226,710 of 303,780
58
The table highlights key income statement metrics including revenue, margins, and net income.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations 1 hit
59
The table compares standard H1 2023/2022 figures with an adjusted H1 2023 column.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations 1 hit
61
Values are in millions of Euros (€M).Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations 1 hit
63
Kering | Investor Presentation Deck | 63 slidesKering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations 1 hit
02
Kymera | Investor Presentation Deck | 41 slidesKymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
03
The slide uses a split-layout with a branding/mission sidebar and a bulleted list of key achievements.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
Kymera | Investor Presentation Deck | 41 slidesKymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
TPD = Targeted Protein Degradation. UD = Undrugged, ID = Inadequately drugged.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · Solution1 hit
06
The slide uses a standard pharmaceutical pipeline table format.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses an abstract, scientific-looking background, likely representing molecular or biological structures.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
08
Includes a biological pathway diagram and a specific 'Degrader Advantage' callout box.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
10
Kymera | Investor Presentation Deck | 41 slidesKymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
11
Includes both a longitudinal line chart of IRAK4 reduction and a grouped bar chart with a summary table for cytokine inhibition.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
12
Includes PK/PD correlation, IRAK4 levels in PBMC, and skin lesion reduction data.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
13
The slide displays 12 bar charts representing log2(fold change) for specific genes across individual patients.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
14
Includes error bars representing standard error of the mean; data points are plotted over 42 days.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
15
The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
16
Data includes error bars representing standard error of the mean (S.E. of Mean) or 80% confidence intervals.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
17
The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
The slide highlights a favorable safety profile with no serious adverse events (SAEs) or drug-related infections.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
19
Focuses on partnership dynamics and clinical progress.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
20
Includes clinical trial identifiers and definitions of acronyms in the footer.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
21
The slide uses an abstract, scientific-looking background, likely representing molecular or biological structures.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
24
The slide uses a process flow diagram to illustrate the dose escalation (0.05 to 0.40 mg/kg) leading to MTD/RP2D expansion into four specific patient cohorts.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
25
The table displays adverse events occurring in 2 or more patients. Data includes patient counts and percentages for both 'All' and 'Related' adverse events.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
26
Includes a line chart showing plasma concentration over time and a table summarizing PK parameters (Cmax, AUClast, Vd, CL, t1/2).Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
27
Data presented as % change from C1D1 Predose. Includes time course line chart and dot plot for maximum degradation.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
28
Data from a clinical study of KT-333, showing biomarker response across different dose levels (DL1, DL2, DL3).Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
29
Includes ASH logo and specific clinical trial metrics (DL levels, AE types).Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
30
The slide uses a split-layout: left side for clinical data results, right side for strategic positioning.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit